Get Longevity Research Delivered Weekly
Join thousands of health professionals and curious minds. No spam, ever.
Enter your email to subscribe:
Your AI Longevity Team
Categories
TrendingLatest Summaries
Fresh from academic journals, YouTube, podcasts, and other sources
Two Vitamin E Forms Show Different Links to Cancer and Alzheimer's Mortality
Higher blood levels of two vitamin E forms tracked with lower mortality in older adults, but the findings do not establish supplement benefits.
Removing Sestrins Pushes Cells Toward Cancer-Like Glucose Metabolism
Cells lacking Sestrin stress-response proteins burned more glucose and released more lactate, revealing a potential brake on cancer metabolism.
Researchers Explore Existing Medicines as Kidney Cancer Treatments
A review explores familiar drugs as kidney cancer treatments, but the abstract provides no clinical benefit estimates.
Rapamycin Helps Injured Nerves Recover and Preserves Muscle in Mice
In mice, rapamycin improved nerve repair, preserved muscle, and supported walking recovery after injury. Human benefits remain unproven.
Marathon Running Disrupts Some Recovery Measures More Than Trail Running
In 41 trained runners, a simulated marathon caused greater thigh activation losses and slower recovery than trail runs matched for effort.
Thick Fluid Around Glioblastoma Makes Brain Cancer Cells Smaller and More Invasive
Chinese researchers found that the viscous fluid at a glioblastoma's edge reshapes tumor cells, making them more flexible, more invasive, and changed even after they leave it.
Disabling MTCH2 Boosts Fat Burning in Human Cells and Endurance in Mice
A protein called MTCH2 may influence fat burning and muscle endurance, but the evidence remains limited to cells and mice.
Rituximab for multiple sclerosis linked to a tenfold higher risk of inflammatory bowel disease
A Swedish study of 13,748 MS therapy episodes finds rituximab users developed IBD far more often than users of other modern MS drugs, mostly Crohn disease.
Fitness predicts survival in kidney disease regardless of body weight
In 13,521 veterans with kidney disease, the fittest had about half the mortality risk of the least fit, whatever their BMI. Higher BMI also tracked with lower mortality.
Sirolimus and paclitaxel drug-coated balloons perform similarly in coronary arteries
A meta-analysis of 8 trials and 1,043 patients finds sirolimus- and paclitaxel-coated balloons deliver similar results in coronary artery disease, with a few caveats.
Major Obesity Trials May Miss the Full Burden of GLP-1 Nausea
A review finds major obesity trials tracked nausea without dedicated patient questionnaires, potentially missing its everyday burden.
Gut Bacteria Use Bile Chemistry to Displace Antibiotic-Resistant Enterococci
A bacterial partnership changes bile chemistry to suppress resistant gut microbes, pointing toward new infection-prevention strategies.
Nicotinamide Riboside Improves Skin Flap Survival in Rats
NR protected skin flaps in rats and boosted cellular recycling, pointing to a possible tissue repair application—not proven benefits in humans.
Scientists Map 13,403 KCNQ1 Variants to Clarify Inherited Heart Rhythm Risk
A large laboratory map links KCNQ1 gene changes to abnormal heart rhythms and could help clarify uncertain genetic test results.
Gut-Derived Butyrate Shows Promise for Brain Aging, but Human Evidence Lags
Gut bacteria turn fiber into butyrate, which may influence brain aging. A new review explores the mechanisms—and the gaps in human evidence.
Review Questions Device Safety for Facial Volume Loss After GLP-1 Treatment
Facial tightening devices may affect already depleted fat after GLP-1 weight loss, but direct safety evidence remains limited.
Our Sponsors

Bioscope.AI
AI-Powered Precision Longevity for Physicians on the Leading Edge

Therabot
Therabot: Real Massage. Real Recovery.

Bioscope Foundry
We make it easy to launch your own precision longevity concierge practice

100 Is the New 30
How Playing the Symphony of Longevity Will Enable Us to Live Young for a Lifetime — Jeffrey Gladden, MD, FACC

MySuperFriends
A private world of AI companions — coaches, therapists, teachers, and guides who remember you and grow with you over time.















